Business
Mountain Valley MD Announces Strategic Non-Brokered Private Placement of Units and Concurrent Shares for Debt Transaction
TORONTO, March 31, 2026--THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
About this update from Mountain Valley Md Holdings Inc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":652,"height":246,"url":"https://media.zenfs.com/en/business-wire.com/0ec8cfceca0da3a1017bc74c56fa9753"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/q2RqRIZaNoZbwi6GusX8_Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM2Mg--/https://media.zenfs.com/en/business-wire.com/0ec8cfceca0da3a1017bc74c56fa9753","width":652,"height":246}},"lazy":false},{"type":"text","content":"TORONTO, March 31, 2026--(BUSINESS WIRE)--THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.","length":165,"tagName":"p"},{"type":"text","content":"Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE: MVMD) (OTC: MVMDF) announces that it intends to complete a strategic non-brokered private placement offering of units to bio-tech investors for aggregate gross proceeds of up to CAD $2,000,000 (the "Offering") and, concurrently, two shares for debt transactions (each, a "Shares for Debt Transaction", collectively the "Shares for Debt Transactions"), in each case as described below.","length":499,"tagName":"p"},{"type":"text","content":"Unit Offering","length":13,"tagName":"p"},{"type":"text","content":"Under the terms of the Offering, the Company intends to issue up to 80,000,000 units (each, a "Unit") at a price of CDN $0.025 per Unit. Each Unit will be comprised of one common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant"). Each Warrant will be exercisable to acquire one Common Share at an exercise price of CDN $0.08 per share for a period of 12 months from the date of issuance, subject to acceleration as described below. The Company expects to complete the Offering for the full amount.","length":581,"tagName":"p"},{"type":"text","content":"The Company may, in its sole discretion, accelerate the expiry of the Warrants if the volume-weighted average price of the Common Shares on the Canadian Securities Exchange ("CSE") is equal to or greater than $0.12 for any ten (10) consecutive trading days. In such event, the Company will be entitled to issue a news release announcing the accelerated expiry date, and the Warrant...